IM Cannabis Corp.
IM Cannabis Corp. (IMCC.CN) Financial Performance & Income Statement Overview
View comprehensive annual and quarterly summaries for IM Cannabis Corp. (IMCC.CN), featuring income statements, balance sheets, and cash flow data.
IM Cannabis Corp. (IMCC.CN) Income Statement & Financial Overview
Analyze IM Cannabis Corp.’s IMCC.CN earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $13.34M | $13.88M | $14.75M | $12.06M |
| Cost of Revenue | $10.65M | $10.73M | $13.91M | $10.28M |
| Gross Profit | $2.68M | $3.15M | $844000.00 | $1.78M |
| Gross Profit Ratio | $0.20 | $0.23 | $0.06 | $0.15 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $790000.00 | $4.10M | $3.73M | $4.66M |
| Operating Expenses | $22.37M | $2.19M | -$2.02M | $7.41M |
| Total Costs & Expenses | $33.02M | $12.93M | $17.64M | $17.69M |
| Interest Income | $0.00 | $0.00 | $0.00 | $487000.00 |
| Interest Expense | $0.00 | $0.00 | $1.43M | $501000.00 |
| Depreciation & Amortization | $542000.00 | $451000.00 | $474000.00 | $717000.00 |
| EBITDA | -$1.07M | -$502000.00 | -$2.40M | -$4.91M |
| EBITDA Ratio | -$0.08 | -$0.04 | -$0.16 | -$0.41 |
| Operating Income | -$19.69M | $953000.00 | -$2.89M | -$5.63M |
| Operating Income Ratio | -$1.48 | $0.07 | -$0.20 | -$0.47 |
| Other Income/Expenses (Net) | $18.43M | -$2.06M | -$1.41M | -$501000.00 |
| Income Before Tax | -$1.26M | -$1.11M | -$4.29M | -$6.13M |
| Income Before Tax Ratio | -$0.09 | -$0.08 | -$0.29 | -$0.51 |
| Income Tax Expense | -$47000.00 | -$26000.00 | -$839000.00 | -$111000.00 |
| Net Income | -$1.01M | -$922000.00 | -$3.03M | -$5.62M |
| Net Income Ratio | -$0.08 | -$0.07 | -$0.21 | -$0.47 |
| EPS | -$0.45 | -$0.41 | -$1.38 | -$0.42 |
| Diluted EPS | -$0.45 | -$0.41 | -$1.38 | -$0.42 |
| Weighted Avg Shares Outstanding | $3.09M | $2.23M | $2.19M | $13.39M |
| Weighted Avg Shares Outstanding (Diluted) | $3.09M | $2.23M | $2.19M | $13.39M |
Over the last four quarters, IM Cannabis Corp.'s revenue moved from $12.06M in Q1 2024 to $13.34M in Q4 2024. Operating income in Q4 2024 was -$19.69M, with a strong operating margin of -148%. Despite fluctuations in R&D and SG&A expenses, EBITDA for IM Cannabis Corp. remained robust at -$1.07M, reflecting operational efficiency. Net income dropped to -$1.01M, with an EPS of -$0.45. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan